|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$38.98 |
$39.80 |
$38.47 |
$39.66 |
669.80K | 03/22/2024 |
$39.56 |
$39.96 |
$39.13 |
$39.72 |
319.40K | 03/25/2024 |
$39.78 |
$40.59 |
$39.55 |
$40.16 |
273.40K | 03/26/2024 |
$40.32 |
$40.32 |
$39.44 |
$39.93 |
335.60K | 03/27/2024 |
$40.10 |
$40.91 |
$39.92 |
$40.91 |
362.40K |
|
Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic. | |
|
Collegium Pharmaceutical (COLL) has the following price history information. Looking back at COLL historical stock prices for the last five trading days, on March 21, 2024, COLL opened at $38.98, traded as high as $39.80 and as low as $38.47, and closed at $39.66. Trading volume was a total of 669.80K shares. On March 22, 2024, COLL opened at $39.56, traded as high as $39.96 and as low as $39.13, and closed at $39.72. Trading volume was a total of 319.40K shares. On March 25, 2024, COLL opened at $39.78, traded as high as $40.59 and as low as $39.55, and closed at $40.16. Trading volume was a total of 273.40K shares. On March 26, 2024, COLL opened at $40.32, traded as high as $40.32 and as low as $39.44, and closed at $39.93. Trading volume was a total of 335.60K shares. On March 27, 2024, COLL opened at $40.10, traded as high as $40.91 and as low as $39.92, and closed at $40.91. Trading volume was a total of 362.40K shares.
COLL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Collegium Pharmaceutical shares, starting with a $10,000 purchase of COLL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/08/2015 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$12.95 |
|
End price/share: |
$40.91 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
215.91% |
|
Average Annual Total Return: |
13.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$31,595.19 |
|
Years: |
8.89 |
|
|
|
Date |
Close |
03/21/2024 | $39.66 | 03/22/2024 | $39.72 | 03/25/2024 | $40.16 | 03/26/2024 | $39.93 | 03/27/2024 | $40.91 |
|
|